Despite A Q3 Beat The Rally In Amedisys Stock Appears Overdone

After a 82% rise since the March 16 lows of this year, at the current price of around $249 per share we believe Amedisys stock, a home health and hospice care company, has reached its near-term potential. AMED stock has rallied from $137 to $249 off the recent bottom compared to the S&P...